- Home
- CGON vs CRSR Comparison
CGON vs CRSR Comparison
Compare CGON & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- CRSR
- Stock Information
- Founded
- CGON 2010
- CRSR 1994
- Country
- CGON United States
- CRSR United States
- Employees
- CGON N/A
- CRSR N/A
- Industry
- CGON
- CRSR Computer Manufacturing
- Sector
- CGON
- CRSR Technology
- Exchange
- CGON NYSE
- CRSR Nasdaq
- Market Cap
- CGON 1.3B
- CRSR 1.1B
- IPO Year
- CGON 2024
- CRSR 2020
- Fundamental
- Price
- CGON $23.74
- CRSR $7.55
- Analyst Decision
- CGON Strong Buy
- CRSR Buy
- Analyst Count
- CGON 11
- CRSR 6
- Target Price
- CGON $62.90
- CRSR $10.00
- AVG Volume (30 Days)
- CGON 2.0M
- CRSR 1.1M
- Earning Date
- CGON 05-20-2025
- CRSR 05-06-2025
- Dividend Yield
- CGON N/A
- CRSR N/A
- EPS Growth
- CGON N/A
- CRSR N/A
- EPS
- CGON N/A
- CRSR N/A
- Revenue
- CGON $1,139,000.00
- CRSR $1,348,872,000.00
- Revenue This Year
- CGON N/A
- CRSR $16.15
- Revenue Next Year
- CGON $16,237.24
- CRSR $10.40
- P/E Ratio
- CGON N/A
- CRSR N/A
- Revenue Growth
- CGON 461.08
- CRSR N/A
- 52 Week Low
- CGON $14.80
- CRSR $5.60
- 52 Week High
- CGON $40.47
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- CGON 49.91
- CRSR 52.59
- Support Level
- CGON $21.00
- CRSR $6.18
- Resistance Level
- CGON $30.23
- CRSR $7.55
- Average True Range (ATR)
- CGON 2.33
- CRSR 0.46
- MACD
- CGON 0.06
- CRSR 0.19
- Stochastic Oscillator
- CGON 30.94
- CRSR 87.25
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.